An in-depth overview of enfortumab vedotin plus pembrolizumab, the newly approved treatment for advanced bladder cancer.
An in-depth overview of enfortumab vedotin plus pembrolizumab, the newly approved treatment for advanced bladder cancer.
This presentation provides an in-depth overview of non-muscle invasive bladder cancer, covering risk factors, diagnosis, and treatment options.
A presentation about the surgical management of bladder cancer including TURBT, bladder instillations and radical cystectomy.
An informative webinar exploring the various urinary diversions available to individuals undergoing a radical cystectomy.
A comprehensive overview of bladder cancer, including risk factors, symptoms, diagnosis, staging, grading, and treatment options.
Plain language information on interpreting a bladder cancer pathology report, focusing primarily on cancer grade and stage.
Invaluable perspectives from a panel of BCC Volunteers on diagnosis, treatment decisions, managing side effects, and coping mechanisms.
This presentation provides insights into bladder cancer fundamentals, covering frontline treatment options and latest advancements.
A presentation about the management of muscle invasive bladder cancer that sheds light on current and forthcoming treatment options.
This presentation addresses the history of BCG, how it is used and some current developments.
4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org
Privacy Policy | Donor Bill of Rights
Charitable Reg No. 83612 6060 RR0001
© Bladder Cancer Canada.